> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SRS Seeking Expanded Use for Spanner Prostatic Stent
- URL: https://www.fdaweb.com/srs-seeking-expanded-use-for-spanner-prostatic-stent/
- Published: 2016-08-24T12:00:00.000Z
- Updated: 2026-09-14T21:26:32.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5136604

SRS Medical Systems has gained IDE approval to enroll patients in a study to expand the indications for use for its Spanner Temporary Prostatic Stent. The stent is an alternative to both indwelling (Foley) and intermittent urinary catheters in male patients, according to the company. Currently, it is approved for a single 30-day period in a limited patient population for maintaining continence in men with symptoms of urinary retention. The expanded indication from the new study is expected to allow the device’s long-term use in all patients who are not candidates for traditional prostate treatments. The device comprises two anchors and a silicone tube that is intended to reduce resistance in the bladder neck and prostatic urethra without stenting the external sphincter.